CONSTELLATION PHARMACEUTICALS INC·4

Jul 24, 7:19 PM ET

THIRD ROCK VENTURES LP 4

4 · CONSTELLATION PHARMACEUTICALS INC · Filed Jul 24, 2018

Insider Transaction Report

Form 4
Period: 2018-07-23
Transactions
  • Purchase

    Common Stock

    2018-07-23$15.00/sh+266,667$4,000,0052,983,051 total
  • Conversion

    Series D Preferred Stock

    2018-07-231,086,4110 total
    Common Stock (98,683 underlying)
  • Conversion

    Common Stock

    2018-07-23+2,705,3342,716,384 total
  • Conversion

    Series B Preferred Stock

    2018-07-2310,650,0000 total
    Common Stock (967,389 underlying)
  • Conversion

    Series E Preferred Stock

    2018-07-232,285,6400 total
    Common Stock (266,934 underlying)
  • Conversion

    Series E-1 Preferred Stock

    2018-07-233,107,9300 total
    Common Stock (282,308 underlying)
  • Conversion

    Series A Preferred Stock

    2018-07-2311,000,0000 total
    Common Stock (999,180 underlying)
  • Conversion

    Series F Preferred Stock

    2018-07-231,000,0000 total
    Common Stock (90,840 underlying)
Footnotes (2)
  • [F1]On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
  • [F2]These securities are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION